"Designing Growth Strategies is in our DNA"

Dysmenorrhea Medications Market Size, Share, and Industry Analysis, By Drug Class (NSAIDs, COX-2 Inhibitor, Hormonal Therapy, and Others), By Indication (Primary Dysmenorrhea and Secondary Dysmenorrhea), By Type (OTC and Prescription), By Distribution Channel (Hospital Pharmacy, Drug Stores & Retail Pharmacies, and Online Pharmacy), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI114755

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology of Dysmenorrhea
    2. Overview: Current Treatment & Therapies for Dysmenorrhea
    3. Pipeline Analysis, By Key Players
    4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  5. Global Dysmenorrhea Medications Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. NSAIDs
      2. COX-2 inhibitor 
      3. Hormonal Therapy
      4. Others
    2.  Market Analysis, Insights and Forecast – By Indication
      1. Primary Dysmenorrhea
      2. Secondary Dysmenorrhea
    3. Market Analysis, Insights and Forecast – By Type
      1. OTC
      2. Prescription
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Dysmenorrhea Medications Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. NSAIDs
      2. COX-2 inhibitor 
      3. Hormonal Therapy
      4. Others
    2.  Market Analysis, Insights and Forecast – By Indication
      1. Primary Dysmenorrhea
      2. Secondary Dysmenorrhea
    3. Market Analysis, Insights and Forecast – By Type
      1. OTC
      2. Prescription
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada 
  7. Europe Dysmenorrhea Medications Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. NSAIDs
      2. COX-2 inhibitor 
      3. Hormonal Therapy
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Primary Dysmenorrhea
      2. Secondary Dysmenorrhea
    3. Market Analysis, Insights and Forecast – By Type
      1. OTC
      2. Prescription
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Germany 
      2. U.K.
      3. France 
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Dysmenorrhea Medications Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. NSAIDs
      2. COX-2 inhibitor 
      3. Hormonal Therapy
      4. Others
    2.  Market Analysis, Insights and Forecast – By Indication
      1. Primary Dysmenorrhea
      2. Secondary Dysmenorrhea
    3. Market Analysis, Insights and Forecast – By Type
      1. OTC
      2. Prescription
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Dysmenorrhea Medications Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. NSAIDs
      2. COX-2 inhibitor 
      3. Hormonal Therapy
      4. Others
    2.  Market Analysis, Insights and Forecast – By Indication
      1. Primary Dysmenorrhea
      2. Secondary Dysmenorrhea
    3. Market Analysis, Insights and Forecast – By Type
      1. OTC
      2. Prescription
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Dysmenorrhea Medications Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. NSAIDs
      2. COX-2 inhibitor 
      3. Hormonal Therapy
      4. Others
    2.  Market Analysis, Insights and Forecast – By Indication
      1. Primary Dysmenorrhea
      2. Secondary Dysmenorrhea
    3. Market Analysis, Insights and Forecast – By Type
      1. OTC
      2. Prescription
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability)
      1. Pfizer Inc.
      2. GSK plc
      3. Bayer AG
      4. Novartis AG
      5. Sanofi
      6. Merck & Co., Inc.
      7. Viatris
      8. Zydus Lifesciences
      9. Teva Pharmaceutical Industries Ltd. 
      10. Other Prominent Players
  • 2021-2034
  • 2025
  • 2021-2024
  • 0
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann